Loading…

A study of T sub(1) relaxation time as a measure of liver fibrosis and the influence of confounding histological factors

Liver biopsy is the standard test for the assessment of fibrosis in liver tissue of patients with chronic liver disease. Recent studies have used a non-invasive measure of T sub(1) relaxation time to estimate the degree of fibrosis in a single slice of the liver. Here, we extend this work to measure...

Full description

Saved in:
Bibliographic Details
Published in:NMR in biomedicine 2015-06, Vol.28 (6), p.706-714
Main Authors: Hoad, Caroline L, Palaniyappan, Naaventhan, Kaye, Philip, Chernova, Yulia, James, Martin W, Costigan, Carolyn, Austin, Andrew, Marciani, Luca, Gowland, Penny A, Guha, Indra N, Francis, Susan T, Aithal, Guruprasad P
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liver biopsy is the standard test for the assessment of fibrosis in liver tissue of patients with chronic liver disease. Recent studies have used a non-invasive measure of T sub(1) relaxation time to estimate the degree of fibrosis in a single slice of the liver. Here, we extend this work to measure T sub(1) of the whole liver and investigate the effects of additional histological factors such as steatosis, inflammation and iron accumulation on the relationship between liver T sub(1) and fibrosis. We prospectively enrolled patients who had previously undergone liver biopsy to have MR scans. A non-breath-holding, fast scanning protocol was used to acquire MR relaxation time data (T sub(1) and T sub(2)*), and blood serum was used to determine the enhanced liver fibrosis (ELF) score. Areas under the receiver operator curves (AUROCs) for T sub(1) to detect advanced fibrosis and cirrhosis were derived in a training cohort and then validated in a second cohort. Combining the cohorts, the influence of various histology factors on liver T sub(1) relaxation time was investigated. The AUROCs (95% confidence interval (CI)) for detecting advanced fibrosis (F greater than or equal to 3) and cirrhosis (F=4) for the training cohort were 0.81 (0.65-0.96) and 0.92 (0.81-1.0) respectively (p
ISSN:0952-3480
1099-1492
DOI:10.1002/nbm.3299